Press Release

Press Release: Nigeria AIDS Indicator and Impact Survey

1 Mins read

The Federal Government of Nigeria in its continuous efforts to improve the health indices of its populace will be conducting the Nigeria AIDS Indicator and Impact Survey (NAIIS). This is a national household survey that will determine the distribution of HIV and Hepatitis B & C in the country. It will also assess the uptake of HIV services at the population level and estimate the prevalence of HIV-related risk behaviors in the 36 states of the Federation and the Federal Capital Territory (FCT). The survey is being conducted under the leadership of the Federal Ministry of Health (FMoH) and the National Agency for the Control of AIDS (NACA).

NAIIS will be implemented through close collaboration with state ministries of health (SMoH), state AIDS control agencies (SACA), donor agencies and implementing partners. It will involve conducting interviews and blood tests on voluntary participants who qualify to take part, in randomly selected households across Nigeria.

Members of these households will be requested to take part in the survey to serve as a representation of the entire population in the selected communities. NAIIS will offer household-based HIV counseling and testing, as well as Hepatitis B and C testing. Those who test positive for any of the tests will be referred to suitable health facilities to receive appropriate services. Only individuals who voluntarily agree to participate will be interviewed and have their blood sample tested in a confidential setting in their homes.

NAIIS will begin in June 2018 and will last for a period of about six months across the 36 states and the FCT.

The results of this survey will provide key information that will guide the Government to plan and develop more effective programs to control HIV and Hepatitis in Nigeria leading to healthier individuals and families.

The Federal Government of Nigeria appreciates its various partners including the United State Government, Global funds to Fight AIDS, Tuberculosis and Malaria, UNAIDS, WHO and other organizations who are supporting the implementation of this survey.

Related posts
Press Release

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

10 Mins read
The first volunteer has received a dose in a first-in-human trial of a Lassa vaccine, marking a major milestone in the fight…
Press Release

Lancet Countdown Africa Publishes Landmark Report on Climate Change and Health in Africa

2 Mins read
PRETORIA – Climate change is driving economic losses in developing nations. It’s slowing progress toward the Sustainable Development Goals and worsening threats such…
Press Release

Encouraging results from a first-in-human Phase 1 clinical trial of IAVI’s Lassa vaccine candidate published in New England Journal of Medicine

7 Mins read
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia Key takeaways: NEW YORK, NY –…

36 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *